SEC 13F Intelligence

Managers / Q2 2020 · view latest →

CVI Holdings, LLC

CIK 0001728194 · ONE COMMERCE CENTER, 1201 N. ORANGE STREET, SUITE 715, WILMINGTON, DE, 19801 · 6106172600

Reported Value
$270M
Q2 2020
Positions
70
Filings on Record
25
2019–present window
Filed
Aug 14, 2020
original filing

Summary

Cvi Holdings, LLC reported $270M in U.S.-listed holdings across 70 positions for Q2 2020.

Its largest position, Nikola, represents 12.5% of the portfolio.

Compared with Q1 2020, the fund opened 52 new positions and exited 21.

Portfolio Metrics

Turnover
+7.1%
vs prior filed quarter
Top-10 Concentration
+51.0%
share of reported value
Largest Position
+12.5%
Nikola
New / Exited
52 / 21
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $45MQ4 ’18Q1 ’19: $106MQ2 ’19: $172MQ3 ’19: $131MQ3 ’19Q4 ’19: $71MQ1 ’20: $28MQ2 ’20: $270MQ2 ’20Q3 ’20: $246MQ4 ’20: $536MQ1 ’21: $1.4BQ1 ’21Q2 ’21: $1.5BQ3 ’21: $1.6BQ4 ’21: $1.5BQ4 ’21Q1 ’22: $1.5BQ2 ’22: $1.4BQ3 ’22: $1.3BQ3 ’22Q4 ’22: $784MQ1 ’23: $266MQ2 ’23: $95MQ2 ’23Q3 ’23: $51MQ4 ’23: $48MQ1 ’24: $106MQ1 ’24Q2 ’24: $116Mfilingsflow.com

Portfolio Composition

By security type
Other: 49.2%Common Stock: 31.9%US DOMESTIC: 9.3%ADR: 5.0%REIT: 4.6%Other: 0.0%
  • Other · 49.2% · $133M
  • Common Stock · 31.9% · $86M
  • US DOMESTIC · 9.3% · $25M
  • ADR · 5.0% · $13M
  • REIT · 4.6% · $12M
  • Other · 0.0% · $88,000

Quarter-over-Quarter Changes full breakdown →

vs Q1 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
NIKOLA CORPNEW+1.23M1.23M+$83M$83M
TENCENT MUSIC ENTMT GROUPNEW+1.00M1.00M+$13M$13M
TRANSLATE BIO INCNEW+750.0K750.0K+$13M$13M
GNUSEURGENIUS BRANDS INTL INCNEW+5.97M5.97M+$13M$13M
INNOVATIVE INDL PPTYS INCNEW+140.9K140.9K+$12M$12M
HUDSON EXECUTIVE INVT CORPNEW+1.20M1.20M+$12M$12M
CFRXUSDCONTRAFECT CORPNEW+1.54M1.54M+$10M$10M
NK1USDNANTKWEST INCNEW+787.9K787.9K+$10M$10M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2020

49 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1NIKOLA CORPCOM12.52%$34M500.0K
2TENCENT MUSIC ENTMT GROUPSPON ADS4.99%$13M1.00M
3TRANSLATE BIO INCCOM4.98%$13M750.0K
4GNUSEURGENIUS BRANDS INTL INChistory →COM4.97%$13M5.95M
5INNOVATIVE INDL PPTYS INCCOM4.60%$12M140.9K
6HUDSON EXECUTIVE INVT CORPUNIT 06/21/20254.54%$12M1.20M
7INOVIO PHARMACEUTICALS INCNOTE 6.500% 3/03.69%$10M2.00M
8CFRXUSDCONTRAFECT CORPhistory →COM NEW3.64%$10M1.54M
9NK1USDNANTKWEST INChistory →COM3.59%$10M787.9K
10ARCTARCTURUS THERAPEUTICS HLDG Ihistory →COM3.47%$9M200.0K
11TIMKENSTEEL CORPNOTE 6.000% 6/03.18%$9M10.46M
12GRWGGROWGENERATION CORPhistory →COM2.73%$7M1.07M
13GS ACQUISITION HLDGS CORP IIUNIT 99/99/99991.95%$5M500.0K
14INSEEGO CORPNOTE 3.250% 5/01.94%$5M5.00M
15REPLREPLIMUNE GROUP INChistory →COM1.72%$5M186.2K
16LPROOPEN LENDING CORPhistory →COM CL A1.40%$4M250.0K
17YUNHONG INTLUNIT 99/99/99991.30%$4M350.0K
18SLNOEURSOLENO THERAPEUTICS INChistory →COM NEW1.28%$3M1.55M
19MNKDMANNKIND CORPhistory →COM NEW1.17%$3M1.81M
20FRANCHISE GROUP INCCOM1.16%$3M143.0K
21MAGENTA THERAPEUTICS INCCOM1.15%$3M414.1K
22LQDALIQUIDIA TECHNOLOGIES INCCOM0.83%$2M265.8K
23EROS INTL PLCSHS NEW0.82%$2M700.0K
24ROTH CH ACQUISITION I COUNIT 01/28/20250.75%$2M200.0K
25VTLUSDIMMUNIC INCCOM0.73%$2M163.0K
26PCGPG&E CORPCOM0.60%$2M182.6K
27LEAP THERAPEUTICS INCCOM0.55%$1M704.9K
28TELATELA BIO INCCOM0.54%$1M113.0K
29CSTLCASTLE BIOSCIENCES INCCOM0.52%$1M37.2K
30BIOSIG TECHNOLOGIES INCCOM NEW0.49%$1M183.6K
31SOLYSOLITON INCCOM0.48%$1M166.1K
32BRICKELL BIOTECH INCCOM0.47%$1M1.28M
33SENSEONICS HLDGS INCNOTE 5.250% 2/00.47%$1M1.50M
34MBIOUSDMUSTANG BIO INCCOM0.43%$1M367.9K
35ATNMEURACTINIUM PHARMACEUTICALS INCCOM0.37%$1M2.85M
36SONIM TECHNOLOGIES INCCOM0.30%$811,0001.00M
37QUIKQUICKLOGIC CORPCOM NEW0.29%$795,000259.9K
38MLSSMILESTONE SCIENTIFIC INCCOM NEW0.27%$731,000374.8K
39OGXIEURACHIEVE LIFE SCIENCE INCCOM NEW0.27%$726,0001.83M
40KTOSKRATOS DEFENSE & SEC SOLUTIOCOM NEW0.25%$669,00042.8K
41CURIS INCCOM NEW0.24%$660,000545.6K
42KLR1USDKALEYRA INCCOM0.23%$625,000154.8K
43YATRA ONLINE INCORD SHS0.21%$560,000824.3K
44GLOBUS MARITIME LIMITED NEWCOM0.20%$551,0002.06M
45TTPHEURTETRAPHASE PHARMACEUTICALS ICOM NEW0.19%$524,000208.1K
46KEZAR LIFE SCIENCES INCCOM0.18%$486,00093.8K
47CAN FITE BIOFARMA LTDSPONSORED ADS0.15%$392,000198.0K
48ASSERTIO HOLDINGS INCCOM0.14%$372,000434.3K
49ALTALTIMMUNE INCCOM NEW0.12%$315,00029.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q2 2024$116M144Aug 15, 202413F-HRchanges · EDGAR ↗
Q1 2024$106M157May 7, 202413F-HRchanges · EDGAR ↗
Q4 2023$48M187Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$51M229Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$95M277Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$266M413May 16, 202313F-HRchanges · EDGAR ↗
Q4 2022$784M615Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.3B882Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.4B930Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.5B928May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.5B948Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.6B899Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.5B790Aug 11, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.4B615May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$536M182Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$246M83Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$270M70Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$28M37May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$71M36Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019REVEALED$131M107Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019REVEALED$172M118Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$106M58May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$45M42Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • HEIGHTS CAPITAL MANAGEMENT, INC028-13218
  • CVI Investments, Inc.028-17822

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.